Sign up to save your podcasts
Or
Share Pfizer to seek USFDA nod for ‘emergency use’
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Pfizer to seek USFDA nod for ‘emergency use’
Pharma giant Pfizer and its German collaborator, BioNTech, are likely to submit data on their mRNA Covid-19 vaccine candidate to the USFDA for an Emergency Use Authorisation. This comes after the vaccine is reporting an efficacy rate of 95 per cent.
Listen in.
---
Send in a voice message: https://anchor.fm/business-line/message
View all episodes
By BusinessLinePharma giant Pfizer and its German collaborator, BioNTech, are likely to submit data on their mRNA Covid-19 vaccine candidate to the USFDA for an Emergency Use Authorisation. This comes after the vaccine is reporting an efficacy rate of 95 per cent.
Listen in.
---
Send in a voice message: https://anchor.fm/business-line/message
More shows like BusinessLine Podcasts
View all
Economist Podcasts
4,225 Listeners
WSJ Your Money Briefing
1,713 Listeners
World Business Report
296 Listeners
WSJ Tech News Briefing
1,649 Listeners
Moneycontrol Podcast
14 Listeners
3 Things
57 Listeners
FT News Briefing
684 Listeners
The Intelligence from The Economist
2,592 Listeners
The World in Brief from The Economist
1,089 Listeners
ThePrint
89 Listeners
Finshots Daily
40 Listeners
Top of the Morning
5 Listeners
The Morning Brief
15 Listeners
Daybreak
11 Listeners
The Daily Brief
10 Listeners